Back to Market Feed

Product Information

ROSUVASTATIN CALCIUM 5 MG TAB is a generic product labeled by PuraCap Laboratories LLC, priced at $0.0333 per EA under NDC 24658026190. Its NADAC has been published 153 times since Sep 20, 2023.

FDA first approved this application on Oct 31, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ROSUVASTATIN CALCIUM 5 MG TAB

ROSUVASTATIN CALCIUM
$0.0333per EA

Strength

5 mg/1

NDC

24658026190

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ROSUVASTATIN CALCIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA207752

FDA Approved

10/31/2016

TE Code

AB

On Market Since

8/23/2023

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for ROSUVASTATIN CALCIUM 5 MG TAB has been published 153 times since Sep 20, 2023, and over the history we have for it it has declined 30.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0333 per EA
All-time high$0.0523 (Dec 13, 2023)
All-time low$0.0333 (Aug 19, 2026)
52-week high$0.0389
52-week low$0.0333
Median price$0.0389
Average price$0.0392
Largest weekly change-22.3% (Dec 20, 2023)
Weeks tracked153
Tracking sinceSep 20, 2023

Price History

1W

-2.0%

1M

-2.0%

3M

-4.7%

6M

-2.5%

1Y

-14.5%

3Y

N/A

5Y

N/A

All

-30.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ROSUVASTATIN CALCIUM market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

ATORVASTATIN 10 MG TABLET
Generic
00093505610•Teva Pharmaceuticals USA Inc.
$0.0232
per EA
ATORVASTATIN 10 MG TABLET
Generic
00093505698•Teva Pharmaceuticals USA Inc.
$0.0232
per EA
ATORVASTATIN 10 MG TABLET
Generic
00378395005•Mylan Pharmaceuticals Inc.
$0.0232
per EA
ATORVASTATIN 10 MG TABLET
Generic
00378395077•Mylan Pharmaceuticals Inc.
$0.0232
per EA
ATORVASTATIN 10 MG TABLET
Generic
00904629006•Major Pharmaceuticals
$0.0232
per EA
ATORVASTATIN 10 MG TABLET
Generic
00904629061•Major Pharmaceuticals
$0.0232
per EA
ATORVASTATIN 10 MG TABLET
Generic
16571013609•Rising Pharma Holdings Inc.
$0.0232
per EA
ATORVASTATIN 10 MG TABLET
Generic
16571013610•Rising Pharma Holdings Inc.
$0.0232
per EA
ATORVASTATIN 10 MG TABLET
Generic
16571013650•Rising Pharma Holdings Inc.
$0.0232
per EA
ATORVASTATIN 10 MG TABLET
Generic
16714017301•NorthStar Rx LLC
$0.0232
per EA

Frequently asked questions

What is the NADAC price of ROSUVASTATIN CALCIUM 5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for ROSUVASTATIN CALCIUM 5 MG TAB, manufactured by PuraCap Laboratories LLC, is $0.0333 per EA (NDC 24658026190), effective Aug 19, 2026.

How has the price of ROSUVASTATIN CALCIUM 5 MG TAB changed over time?

Over the history we have for it, the NADAC for ROSUVASTATIN CALCIUM 5 MG TAB has declined 30.2%. It has been tracked across 153 weekly CMS publications since Sep 20, 2023.

What are the highest and lowest recorded NADAC prices for ROSUVASTATIN CALCIUM 5 MG TAB?

Since Sep 20, 2023, the NADAC for ROSUVASTATIN CALCIUM 5 MG TAB has ranged from a low of $0.0333 (Aug 19, 2026) to a high of $0.0523 (Dec 13, 2023), with a median of $0.0389 per EA.

Are there cheaper alternatives to ROSUVASTATIN CALCIUM 5 MG TAB?

No other NADAC-published product currently shares the active ingredient and strength of ROSUVASTATIN CALCIUM 5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ROSUVASTATIN CALCIUM 5 MG TAB?

ROSUVASTATIN CALCIUM 5 MG TAB (NDC 24658026190) is labeled by PuraCap Laboratories LLC, and CMS classifies it as a generic product.